Cargando…

Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model

INTRODUCTION: This paper describes the implementation of novel oral anticoagulants (NOACs) through an anticoagulation nurse. Logistics and tasks of this new function are described and preliminary data are presented. METHODS: Indications for NOACs are explained by the treating cardiologists. Thereaft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folkeringa, R. J., Geven, L. M., Veldhuis, T., Hoogendoorn, M., Hofma, S. H., Van Roon, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2014
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031353/ https://www.ncbi.nlm.nih.gov/pubmed/24590768 http://dx.doi.org/10.1007/s12471-014-0529-9

Ejemplares similares

Effect of oral anticoagulants on the outcome of faecal immunochemical test
por: Bujanda, L, et al.
Publicado: (2014)

Inpatient Oral Anticoagulation Management by Clinical Pharmacists: Safety and Cost effectiveness
por: Hosmane, Sharath R., et al.
Publicado: (2010)

Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience
por: Schiavone, Marco, et al.
Publicado: (2021)

Effects of different anticoagulants on glycated albumin quantification
por: Bonetti, Graziella, et al.
Publicado: (2018)

Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants
por: SÜßMUTH, Kira, et al.
Publicado: (2020)

Psychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary report
por: Fumagalli, Stefano, et al.
Publicado: (2014)

Why anticoagulant studies on sepsis fail frequently --- start with SCARLET
por: Guo, Jian-Ying, et al.
Publicado: (2023)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
por: Morgan, Alice, et al.
Publicado: (2018)

Spontaneous Haematomas in Anticoagulated Covid-19 Patients: Diagnosis and Treatment by Embolization
por: López-Martínez, Lorena, et al.
Publicado: (2022)

Novel oral anticoagulants: the translation of ‘de Leidraad’ into daily clinical practice
por: Jaspers Focks, J., et al.
Publicado: (2014)

Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015
por: Feistritzer, Clemens, et al.
Publicado: (2016)

Reversal of the anticoagulant and anti-hemostatic effect of low molecular weight heparin by direct prothrombin activation
por: Andrade, S.A., et al.
Publicado: (2012)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

New oral anticoagulants – a practical guide
por: Ciurus, Tomasz, et al.
Publicado: (2015)

Comparative effectiveness of oral anticoagulants in everyday practice
por: Camm, A John, et al.
Publicado: (2021)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Venous Doppler ultrasound in critically Ill COVID-19 patients: game changer in anticoagulation therapy
por: Alfageme, Marta, et al.
Publicado: (2020)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
por: Hu, Tiffany Y, et al.
Publicado: (2016)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

The effect of anticoagulants in blood collection tubes on Plasmodium falciparum transmission in direct membrane feeding assays
por: Graumans, Wouter, et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Patient Education on Oral Anticoagulation
por: Hawes, Emily M
Publicado: (2018)

Trends in direct oral anticoagulant use in patients presenting with acute stroke
por: Teow, Kang H., et al.
Publicado: (2022)

Novel antidotes for target specific oral anticoagulants
por: Das, Arundhati, et al.
Publicado: (2015)

The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention
por: Wong, Kitty H. F., et al.
Publicado: (2019)

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
por: Toth, Peter P
Publicado: (2016)

Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use
por: Deng, Zhen-Ling, et al.
Publicado: (2022)

Implications of direct oral anticoagulation and antiplatelet therapy in intensive care
por: Willcox, Abbey, et al.
Publicado: (2023)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

The role of oral anticoagulants in epistaxis
por: Buchberger, A. M. S., et al.
Publicado: (2018)

Practical Considerations for Use of Direct Oral Anticoagulants in Children
por: Whitworth, Hilary, et al.
Publicado: (2022)

Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njo2pa3utmh76f0her961ev3ke